Keros Therapeutics Inc (KROS)

Revenue

$15.01M

TTM · Period ending: · USD

KROS logo

KROS Revenue

Latest reported$15.01M
KROS TTM Revenue ($10.00M → $15.01M)
High-resolution chart · PNG

KROS revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Keros Therapeutics Inc Revenue — Trailing twelve months (TTM) (USD)
Period endingRevenue (USD)
15,014,000
33,182,000
244,061,000
246,718,000
232,844,000
214,713,000
3,550,000
651,000
271,000
234,000
151,000
8,000
0
0
0
20,000,000
20,000,000
20,100,000
20,100,000
100,000
100,000
0
0
2,500,000
5,000,000
7,500,000
10,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.